Profile for Japan Patent: 2011513035
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: 2011513035
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Mar 10, 2029 | Assertio Speclty | OTREXUP | methotrexate |
| ⤷ Start Trial | Mar 10, 2029 | Assertio Speclty | OTREXUP | methotrexate |
| ⤷ Start Trial | May 27, 2031 | Assertio Speclty | OTREXUP | methotrexate |
| ⤷ Start Trial | Mar 10, 2029 | Assertio Speclty | OTREXUP | methotrexate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
